Literature DB >> 15870552

Multi-centre investigation on reference ranges for ROTEM thromboelastometry.

Thomas Lang1, Anne Bauters, Siegmund L Braun, Bernd Pötzsch, Klaus-Werner von Pape, Hans-Jürgen Kolde, Meret Lakner.   

Abstract

Reagent-supported thromboelastometry (TEM) with the ROTEM Whole Blood Haemostasis Analyser is an enhancement of thromboelastography, a method that is increasingly used for the point of care monitoring of acute perioperative bleeding disorders. We investigated the reference ranges of two activated tests (INTEM and EXTEM) and a test analysing specifically the fibrin component of coagulation (FIBTEM) in a multi-centre approach. The reference ranges obtained for the clotting time (CT), clot formation time (CFT), alpha angle (ALP), maximum clot firmness (MCF) and clot lysis parameters were comparable from centre to centre. INTEM: CT equals; 137-246 s, CFT equals; 40-100 s, MCF equals; 52-72 mm. EXTEM: CT equals; 42-74 s, CFT equals; 46-148 s, MCF equals; 49-71 mm. FIBTEM: MCF equals; 9-25 mm. ROTEM whole blood coagulation correlated weakly with a trend towards enhanced coagulation in females compared with males and in advanced age. The repeatability (within-run imprecision) of the results was dependent on the test with the following coefficients of variation: 1-5% (clot firmness, alpha angle), 3-12% (CT, CFT), 6-13% (FIBTEM clot firmness). Citrated blood samples were stable for ROTEM analysis stored within 6 h from drawing. In summary, the data showed that ROTEM thromboelastometry yields consistent values between centres and that providing general orientating reference ranges seems to be possible.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15870552     DOI: 10.1097/01.mbc.0000169225.31173.19

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  88 in total

1.  Thromboelastometry Based Early Goal-Directed Coagulation Management Reduces Blood Transfusion Requirements, Adverse Events, and Costs in Acute Type A Aortic Dissection: A Pilot Study.

Authors:  Alexander A Hanke; Ulf Herold; Daniel Dirkmann; Konstantinos Tsagakis; Heinz Jakob; Klaus Görlinger
Journal:  Transfus Med Hemother       Date:  2012-03-15       Impact factor: 3.747

2.  Cupincin: A Novel Cupin Domain Containing Protease from Rice (Oryza sativa L.) Bran Comprising of Procoagulant and Fibrinogenolytic Activity.

Authors:  Roopesh Sreedhar; Purnima Kaul Tiku
Journal:  Indian J Hematol Blood Transfus       Date:  2017-08-11       Impact factor: 0.900

Review 3.  Acute blood loss during burn and soft tissue excisions: An observational study of blood product resuscitation practices and focused review.

Authors:  Heather F Pidcoke; Claire L Isbell; Maryanne C Herzig; Chriselda G Fedyk; Beverly S Schaffer; Kevin K Chung; Christopher E White; Steven E Wolf; Charles E Wade; Andrew P Cap
Journal:  J Trauma Acute Care Surg       Date:  2015-06       Impact factor: 3.313

4.  Concerning Hänecke P, Klouche M: Thrombelastography Today: Practicability and Analytical Power. Transfus Med Hemother 2007;34:421-428.

Authors:  Thomas Ebinger
Journal:  Transfus Med Hemother       Date:  2008-07-21       Impact factor: 3.747

5.  Thromboelastometry and Thrombelastography Analysis under Normal Physiological Conditions - Systematic Review.

Authors:  Marcel Adler; Sandra Ivic; Nicolas S Bodmer; Hugo Ten Cate; Lucas M Bachmann; Walter A Wuillemin; Michael Nagler
Journal:  Transfus Med Hemother       Date:  2017-03-08       Impact factor: 3.747

6.  Persistent hypocoagulability in patients with septic shock predicts greater hospital mortality: impact of impaired thrombin generation.

Authors:  Paul B Massion; Pierre Peters; Didier Ledoux; Valentine Zimermann; Jean-Luc Canivet; Pierre P Massion; Pierre Damas; André Gothot
Journal:  Intensive Care Med       Date:  2012-06-27       Impact factor: 17.440

Review 7.  Fibrinolysis in trauma: a review.

Authors:  M J Madurska; K A Sachse; J O Jansen; T E Rasmussen; J J Morrison
Journal:  Eur J Trauma Emerg Surg       Date:  2017-09-16       Impact factor: 3.693

8.  Reversal of apixaban induced alterations in haemostasis by different coagulation factor concentrates in patients after hip or knee replacement surgery.

Authors:  Katrin Schmidt; Kerstin Krüger; Elisabeth Langer; Martin Schmutzler; Elke Johnen; Klaus D Wernecke; Christian von Heymann; Mareike K Körber
Journal:  Blood Transfus       Date:  2018-05-08       Impact factor: 3.443

9.  HES 130/0.4 impairs haemostasis and stimulates pro-inflammatory blood platelet function.

Authors:  Maik Sossdorf; Sascha Marx; Barbara Schaarschmidt; Gordon P Otto; Ralf A Claus; Konrad Reinhart; Christiane S Hartog; Wolfgang Lösche
Journal:  Crit Care       Date:  2009-12-22       Impact factor: 9.097

10.  Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate.

Authors:  Herbert Schöchl; Ulrike Nienaber; Georg Hofer; Wolfgang Voelckel; Csilla Jambor; Gisela Scharbert; Sibylle Kozek-Langenecker; Cristina Solomon
Journal:  Crit Care       Date:  2010-04-07       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.